Related Experiment Video
Updated: Jul 20, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Immunologic control of HIV-1.
Rajesh T Gandhi1, Bruce D Walker
1Partners AIDS Research Center and Infectious Diseases Division, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, Massachusetts 02114, USA. rgandhi@partners.org
Immunotherapy aims to boost immune responses against human immunodeficiency virus-1 (HIV-1) to control the virus. New strategies are being developed based on understanding how immune cells and antibodies can manage HIV-1 infection.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Human immunodeficiency virus-1 (HIV-1) infection severely weakens the immune system by destroying CD4+ T cells.
- While antiretroviral therapy is effective, it has limitations, necessitating alternative treatment strategies.
- Understanding natural immune control of HIV-1 is crucial for developing new therapies.
Purpose of the Study:
- To explore immunotherapy as a novel approach to treating HIV-1 infection.
- To investigate the potential of boosting immune responses for viral control.
- To leverage insights from natural HIV-1 controllers for therapeutic development.
Main Methods:
- Review of recent studies on immune responses in HIV-1 infection.
- Analysis of the roles of CD4+ helper responses, CD8+ T cell activity, and antibodies in viral control.
- Examination of immunologic correlates associated with managing HIV-1 without antiretroviral therapy.
Main Results:
- Recent studies indicate that CD4+ helper responses, CD8+ T cell activity, and antibodies can contribute to controlling HIV-1 in some individuals.
- These immune components are key factors in achieving viral containment without continuous antiretroviral treatment.
- The findings highlight specific immune mechanisms that can be targeted for therapeutic intervention.
Conclusions:
- Immunotherapy represents a promising strategy for HIV-1 treatment by enhancing the body's own immune defenses.
- Targeting CD4+ helper cells, CD8+ T cells, and antibody production could lead to effective immune-based therapies.
- Further development and testing of these immunotherapeutic strategies are underway to combat HIV-1 infection.
More Related Videos
09:26In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Retrovirus Life Cycles
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly